WO2001013949A3 - Medizinisches präparat zur behandlung von arthrose, arthritis und anderen rheumatischen gelenkerkrankungen - Google Patents

Medizinisches präparat zur behandlung von arthrose, arthritis und anderen rheumatischen gelenkerkrankungen Download PDF

Info

Publication number
WO2001013949A3
WO2001013949A3 PCT/DE2000/002720 DE0002720W WO0113949A3 WO 2001013949 A3 WO2001013949 A3 WO 2001013949A3 DE 0002720 W DE0002720 W DE 0002720W WO 0113949 A3 WO0113949 A3 WO 0113949A3
Authority
WO
WIPO (PCT)
Prior art keywords
arthritis
joint diseases
medical preparation
groups
shelled
Prior art date
Application number
PCT/DE2000/002720
Other languages
English (en)
French (fr)
Other versions
WO2001013949A2 (de
Inventor
Andreas Jordan
Original Assignee
Magforce Applic Gmbh
Andreas Jordan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magforce Applic Gmbh, Andreas Jordan filed Critical Magforce Applic Gmbh
Priority to AT00967511T priority Critical patent/ATE302612T1/de
Priority to US10/048,037 priority patent/US6669623B1/en
Priority to AU77695/00A priority patent/AU7769500A/en
Priority to EP00967511A priority patent/EP1204426B1/de
Priority to JP2001518085A priority patent/JP2003507434A/ja
Priority to DE50011033T priority patent/DE50011033D1/de
Publication of WO2001013949A2 publication Critical patent/WO2001013949A2/de
Publication of WO2001013949A3 publication Critical patent/WO2001013949A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Ein medizinisches Präparat zur Behandlung von Arthrose, Arthritis und rheumatischen Erkrankungen umfaßt eine Suspension aus ein- oder mehrschaligen nanoskaligen Teilchen, die jeweils aus einem eisenoxidhaltigen Kern und einer inneren Schale mit zur Bildung von kationischen Gruppen befähigten Gruppen bzw. Wahlweise mindestens einer äußeren Schale mit neutralen und/oder anionischen Gruppen bestehen. An die innere Schale sind Radionuklide und unter Wärmeeinfluß zytotoxisch wirkende Stoffe gebunden. Das in den Gelenkspalt injizierte und einem magnetischen Wechselfeld ausgesetzte Präparat verspricht aufgrund der hohen Phagozytoserate und der trimodalen kombinatorischen Wirkung von Thermo-, Radio- und Chemotherapie einen hervorragenden Therapieerfolg.
PCT/DE2000/002720 1999-08-19 2000-08-09 Medizinisches präparat zur behandlung von arthrose, arthritis und anderen rheumatischen gelenkerkrankungen WO2001013949A2 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AT00967511T ATE302612T1 (de) 1999-08-19 2000-08-09 Medizinisches präparat zur behandlung von arthrose, arthritis und anderen rheumatischen gelenkerkrankungen
US10/048,037 US6669623B1 (en) 1999-08-19 2000-08-09 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases
AU77695/00A AU7769500A (en) 1999-08-19 2000-08-09 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases
EP00967511A EP1204426B1 (de) 1999-08-19 2000-08-09 Medizinisches präparat zur behandlung von arthrose, arthritis und anderen rheumatischen gelenkerkrankungen
JP2001518085A JP2003507434A (ja) 1999-08-19 2000-08-09 関節症、関節炎、及び他のリウマチ性関節疾患を治療するための医療用調製物
DE50011033T DE50011033D1 (de) 1999-08-19 2000-08-09 Medizinisches präparat zur behandlung von arthrose, arthritis und anderen rheumatischen gelenkerkrankungen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19940220A DE19940220B4 (de) 1999-08-19 1999-08-19 Medizinisches Präparat zur Behandlung von Arthrose, Arthritis und anderen rheumatischen Gelenkerkrankungen
DE19940220.5 1999-08-19

Publications (2)

Publication Number Publication Date
WO2001013949A2 WO2001013949A2 (de) 2001-03-01
WO2001013949A3 true WO2001013949A3 (de) 2001-12-20

Family

ID=7919494

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2000/002720 WO2001013949A2 (de) 1999-08-19 2000-08-09 Medizinisches präparat zur behandlung von arthrose, arthritis und anderen rheumatischen gelenkerkrankungen

Country Status (8)

Country Link
US (1) US6669623B1 (de)
EP (1) EP1204426B1 (de)
JP (1) JP2003507434A (de)
AT (1) ATE302612T1 (de)
AU (1) AU7769500A (de)
DE (2) DE19940220B4 (de)
ES (1) ES2249297T3 (de)
WO (1) WO2001013949A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7951061B2 (en) * 2001-07-25 2011-05-31 Allan Foreman Devices for targeted delivery of thermotherapy, and methods related thereto
US7731648B2 (en) * 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
WO2003022308A2 (en) * 2001-09-13 2003-03-20 Scientific Generics Limited Therapeutic insert and therapeutic method
JP2005519761A (ja) * 2002-02-04 2005-07-07 ナノフェイズ テクノロジーズ コーポレイション 水性媒体中の安定なナノ粒子分散体
DE102005039579B4 (de) 2005-08-19 2022-06-30 Magforce Ag Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
US20080281386A1 (en) * 2007-05-09 2008-11-13 Tessaron Medical, Inc. Systems and methods for treating body tissue
US20080281318A1 (en) * 2007-05-09 2008-11-13 Tessaron Medical, Inc. Systems and methods for inductive heat treatment of body tissue
US20090157069A1 (en) * 2007-12-06 2009-06-18 Curtis Tom Systems and methods for thermal treatment of body tissue
DE102009058650A1 (de) 2009-12-16 2011-06-22 Leibniz-Institut für Neue Materialien gemeinnützige GmbH, 66123 Magnetische Kompositpartikel
WO2011128896A1 (en) * 2010-04-12 2011-10-20 Ramot At Tel-Aviv University Ltd. Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders
PL2683440T3 (pl) 2011-03-10 2016-05-31 Magforce Ag Wspomagane komputerowo narzędzie symulacyjne do pomocy w planowaniu termoterapii
WO2013020701A2 (en) 2011-08-10 2013-02-14 Magforce Ag Agglomerating magnetic alkoxysilane-coated nanoparticles
DE102012213839B4 (de) * 2012-08-03 2017-06-14 Leibniz-Institut Für Festkörper- Und Werkstoffforschung Dresden E.V. Verfahren zur kontrollierten Bewegung von Objekten in flüssigen Medien

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758429A (en) * 1985-11-04 1988-07-19 Gordon Robert T Method for the treatment of arthritis and inflammatory joint diseases
US5149319A (en) * 1990-09-11 1992-09-22 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids
DE19726282A1 (de) * 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303636A (en) * 1974-08-20 1981-12-01 Gordon Robert T Cancer treatment
US4590922A (en) * 1983-08-19 1986-05-27 Gordon Robert T Use of ferromagnetic, paramagnetic and diamagnetic particles in the treatment of infectious diseases
US5655546A (en) * 1995-06-07 1997-08-12 Halpern; Alan A. Method for cartilage repair
DE19716732C2 (de) * 1997-03-07 1999-03-25 Max Delbrueck Centrum Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758429A (en) * 1985-11-04 1988-07-19 Gordon Robert T Method for the treatment of arthritis and inflammatory joint diseases
US5149319A (en) * 1990-09-11 1992-09-22 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids
DE19726282A1 (de) * 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; MASAI, AKIRA: "Development of Anticancer-Agent-Releasing Microcapsules for Chemotherapy Combined with Embolo- Hyperthermic Therapy.", XP002174710, retrieved from STN Database accession no. PREV199598223481 *
GRADY E.D. ET AL: "Combination of internal radiation therapy and hyperthermia to treat liver cancer.", SOUTHERN MEDICAL JOURNAL, (1983) 76/9 (1101-1105). CODEN: SMJOAV, XP001015654 *
NIPPON ACTA RADIOLOGICA, (1995) VOL. 55, NO. 1, PP. 50-57. *

Also Published As

Publication number Publication date
WO2001013949A2 (de) 2001-03-01
US6669623B1 (en) 2003-12-30
ES2249297T3 (es) 2006-04-01
EP1204426B1 (de) 2005-08-24
DE19940220B4 (de) 2007-05-03
ATE302612T1 (de) 2005-09-15
DE50011033D1 (de) 2005-09-29
EP1204426A2 (de) 2002-05-15
DE19940220A1 (de) 2001-02-22
AU7769500A (en) 2001-03-19
JP2003507434A (ja) 2003-02-25

Similar Documents

Publication Publication Date Title
WO2001013949A3 (de) Medizinisches präparat zur behandlung von arthrose, arthritis und anderen rheumatischen gelenkerkrankungen
US4106488A (en) Cancer treatment method
US4303636A (en) Cancer treatment
EP1409654A4 (de) Immunologische kontrolle des beta-amyloid gehaltes in vivo
HUP0203523A3 (en) The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses
CA2253963A1 (en) Targeted hysteresis hyperthermia as a method for treating diseased tissue
EP1421948A3 (de) Verwendung von Botulinum Toxine zur Behandlung vom Schwitzen bei Menschen
DK1001811T3 (da) Nanopartikler med en jernoxidholdig kerne omgivet af mindst to skaller
CA2296057A1 (en) Therapeutic prostatic thermotherapy
MXPA04004355A (es) Tratamiento de combinacion que comprende zd6474 y un taxano.
El‐Atti et al. Use of probiotics in the management of chemotherapy‐induced diarrhea: a case study
Latha et al. Efficacy of yoga therapy in the management of headaches.
WO2001028587A3 (en) Magnetic targeted carrier
Beale et al. ECT for OCD.
US20150157872A1 (en) Device for Treating Cancer by Hyperthermia and the Method Thereof
Kahn et al. Schizophrenia, panic anxiety, and alprazolam.
EP3359141B1 (de) Mischung aus lafesih-magnetnanopartikel mit unterschiedlichen curie-temperaturen curie zur verbesserung der induktiven heizeffizienz für hyperthermietherapie
CA2363973A1 (en) Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
MD798G2 (ro) Metoda de tratament a cancerului mamar
GB2024007A (en) Cancer-treating composition containing inductively-heatable particles
CN110292632A (zh) 一种肿瘤热疗粒子
WO1996027008A3 (de) Mittel zur therapie von tumoren und anderen hyperplasien
Szabo Fluoxetine and sumatriptan: possibly a counterproductive combination.
GEP20022670B (en) Complex Medicinal and Prophylactic Preparation "Mikoliz" Against Mixed Infections
Pettinati Speed of ECT?

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AU BA BB BG BR BZ CA CN CR CU CZ DM DZ EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MD MG MK MN MX NO NZ PL RO SG SI SK TR TT UA US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000967511

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AU BA BB BG BR BZ CA CN CR CU CZ DM DZ EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MD MG MK MN MX NO NZ PL RO SG SI SK TR TT UA US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10048037

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000967511

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2000967511

Country of ref document: EP